Keep it real
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I haven't heard it yet. Still await pk/pd to determine optimum p2/p3
Without PK/PD data, without and IND, don't think so!
Gotta start research somewhere. Gone are the Medieval practices of administring directly to man.
And it was paid by an outside organization, great!
Did not spot any.
However self paid promo's are so often abused. And given our trading volume it seems it seems the article is not attracting more attention towards TPIV.
FYI, paid promotion
2016 MicrocapResearch Fee Disclosure:
Received $10,000 from unrelated third party to raise investor awareness in TapImmune Inc. (TPIV)
23 actors??? Who??
Yesterdays trade was a textbook example of technical trading as described by 123Tom
Oh by the way what other Alzheimer drugs were recently approved?
273 keeps showing efficacy after 24 months
FDA are now approving alzheimers drugs willy nilly.
Existing warrants are still there to raise cash if needed.
It appears that other Alzheimers drugs have been approved recently
You do understand that 4 phase trials are running or to be started. What do you expect? These trials need time to run before we get results.
Wasn't this supposed to start 1H 2017?
The combo is worse then 2-73 standalone. Missling had all but abondonnned this
Luckily we have our stop losses in place to protect our AVXL investment!
No, that's with the one with DOD grant and a patient population of 280. Recently someone posted on here that some clinics were gonna start recruiting soon.
I can only speculate, but the trials are initiatilg or running. What can he do between now and data readout? Twiddle his thumbs ?
We are in a quiet news period, awaiting interim results.
Consider the following: dr Bonfiglio was attracted for his expertise in financing, strategy and corporate profiling.
It seems to me all his goals are achieved.
1) warrants restructured and financing assured
2) uplisting to Nasdaq
3) collaborations with Memorial Sloan Kettering and AstraZeneca
4) 4 Phase2 trials initiated or running
Not much he can do at TPIV for the moment. The trials have to run their course and this takes time. I'm guessing he got borred and wants a new challenge.
And of course these millions of clients are well reflected in our anemic volume.
Missling did provide guidance by saying it would be released when ready. So no holding back. Anything different would be a material event
Pretty sure that the market has no clue who Anavex is or what drugs we have in the pipeline.
Yeah sure one of Anavex 9 employees is busy monitoring this Ihub board...
Oh very volatile indeed: from 5.85 to 5.75
Market what's to hear trial starts, partnerships,...
It is not immaterial when Missling has stated publicly on multiple occasions that it would be released when available.
Any update on the average shareprice?
Remember 2015 when the shareprice was walked up in order to trigger warrants?
Same could happen again
There will be no offering. Warrants have been converted in the past to raise cash and there are still some left at various trigger prices.
It's a quote from an Anavex PR, to be found on the website.
Not too difficult to find
Source is an Anavex PR. Calling that misleading?
I am an investor, expecting return on investment. Yes the run was nice between April and Nov 2015. Waiting to bring the stock price to a higher level.
Incorrect. It was never said they had enough data to start.
But hinting at working with FDA on p2/3 and 18 months later not started yet and no official guidance, is annoying.
Nov 2015 a pr went out saying they are working with the FDA to do a p2/3. We are now April 2017, and waiting.
Luckily no downward spiral!
Beware of fake volume and liquidity pools. Saw similiar in the Alzheimer space.
Great day, but cautious with conclusions is my advice.
Baseless claim.
I would call it not doing due dillegence
Please don't confuse shareholder confidence with postings on an anonymous board. Institutional ownership is increasing quarter after quarter.
Why blame a company for personal bad investment decisions. Did they force to hold the stock?
The SEC form said there were no ongoing takeover discussions.
Not enough people read SEC forms
It seems many people know many people who attended the Anavex meeting.
Pitty there was no livestream so we could all hear what was actually said.